General Information
Version
2.2
Revision date
2023-04-14
Product name
CRESEMBA (Isavuconazonium Sulfate) Capsules
1.2.1 Relevant identified uses
Pharmaceutical research, manufacture of clinical drug product, and clinical use
Icons in SDS
Company Information
company name
Astellas US LLC
Section 2
SECTION 2: Hazards identification
This product is a drug, as defined by the US Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) It is in solid, final form for direct administration to the patient. Therefore, is it exempt from the US 2012 Hazard Communication Standard, as defined in the 29 CFR 1910.1200(b)(5)(iii).
